(−)-Daucic acid: Proof of -lyxo configuration, synthesis of its -ribo, -xylo, -arabino and -lyxo analogs, and biosynthetic implications

The dimethyl esters of the 2,6-anhydro-3-deoxy-hept-2-enaric acids with -xylo, -lyxo, -arabino, -lyxo- and -ribo-configuration were synthesized from -galactose and -mannose, respectively, and further characterized by their di-O-acetyl and di-O-benzoyl derivatives. Comparison of their physical data with those of Daucus carota derived products revealed (−)-daucic acid to have -lyxo-configuration 46 rather than the previously assigned -xylo stereochemistry 1. Dimethyl daucate 43 could be converted by acid-induced ring contraction and dehydration into naturally occurring (+)-osbeckic acid 47, thereby proving its (S)-configuration. Configurational identity in the pyranoid rings of (−)-daucic acid and KDO, together with available biosynthetic evidence on chelidonic acid 4, a leaf closing factor, suggests a joint, KDO 8-P-based pathway for their biosynthesis in plants.     

Conformational studies on L-serine phosphate and hydrated L-serine phosphate using ab initio SCF calculations

Ab initio MO -LCAO -SCF calculations using an STO -3G basis set were performed to find the most stable conformations of L -serine phosphate and hydrated L -serine phosphate. The most favorable conformation of L -serine phosphate is found to be one where the bond sequence O? C? C? C is trans and P? O? C? C gauche, and a very short hydrogen bond is formed between an oxygen atom of the phosphate group and a hydrogen atom of the ammonium group. For hydrated L -serine phosphate, a bridge-type hydration in which a water molecule links a phosphate oxygen and an ammonium hydrogen displays particularly low energy. In the four-hydrated L -serine phosphate anion, the most favorable conformation is such a bridged one having a rather extended configuration with regard to the bond sequences O? C? C? C and P? O? C? C.     

Antihypertensive Effect of Angiotensin‐Converting Enzyme Inhibitory Peptide Obtained from Hen Ovotransferrin

Angiotensin I‐converting enzyme (ACE) inhibitory peptide was isolated from the hen ovotransferrin hydrolysate using chymotryptic hydrolysis by two steps of reverse‐phase high‐performance liquid chromatography. The amino sequence of this novel peptide was identified as Lys‐Val‐Arg‐Glu‐Gly‐Thr‐Thr‐Tyr that inhibited ACE activity in vitro in a concentration‐dependent manner with an effective concentration (IC₅₀) of 102.8 μM. Also, this inhibition was identified as noncompetitive using the Lineweaver‐Burk plot. Moreover, the antihypertensive action of this novel peptide was investigated by an intravenous injection into spontaneously hypertensive rats (SHR). A dose‐dependent reduction of systolic blood pressure by this peptide was observed after 40 min of treatment and it decreased the blood pressure markedly at the maximal dose (1 nmol/mL/kg). The maximal blood pressure lowering activity of this peptide was calculated as 163% of captopril (10 pmol/mL/kg) that was used as positive control. In conclusion, the obtained data suggests that Lys‐Val‐Arg‐Glu‐Gly‐Thr‐Thr‐Tyr has an ability to inhibit ACE activity and decrease the systolic blood pressure in hypertensive animals.     

Palladium-catalyzed aminoallylation of activated olefins with allylic halides and phthalimide

The three-component aminoallylation reaction of the activated olefins 2 with the phthalimide 1a and allyl chloride proceeded very smoothly in the presence of Pd(2)dba(3).CHCl(3) (5 mol %)/P(4-FC(6)H(4))(3) (40 mol %) and Cs(2)CO(3) (3 equiv against 2) in dichloromethane at room temperature to give the corresponding aminoallylated products, N-pent-4-enylphthalimides 3, in 58-99% yields. The reaction of oxazolidinone 1b also proceeded very smoothly to give N-(2,2-dicyano-1-phenylpent-4-enyl)oxazolidinone in a quantitative yield; however, the Tsuji-Trost-type allylation products 4 were obtained in the case of dibenzylamine, N-tosylaniline, and pyrrolidin-2-one. Further, 2 underwent cycloaddition with N-tosylvinylaziridine 9a in the presence of Pd(2)dba(3).CHCl(3) (5 mol %)/P(4-FC(6)H(4))(3) (40 mol %) in THF at room temperature, giving the corresponding pyrrolidines 11 in 69-99% yields.     

Synthesis of crown ether-terminated poly(methyl methacrylate) by radical chain transfer polymerization

Mercapto-16-crown-5 was prepared starting from tetraethyleneglycol and 3-chloro-2-chloromethyl-1-propene. Radical polymerization of methyl methacrylate was carried out in the presence of mercapto-16-crown-5 as a chain transfer agent to give crown ether-terminated poly(methyl methacrylate). The end crown group was characterized by IR and ¹H-NMR spectra. Sodium cation was selectively extracted by this crown-containing polymer. The molecular weight of the obtained polymer had influence upon the ability of extraction of sodium cation.     

A new route to 3-alkyl-2,5-di-t-butyl-2,4-cyclopentadienones from 4-alkyl-2,6-di-t-butylphenols

Base-catalyzed reaction of 5-acylmethyl-2,5-di-$\text{t}$-butyl-4-oxa-2-cyclopentenones selectively derived from 4-alkyl-2,6-di-$\text{t}$-butylphenols $\text{via}$ three steps involving oxygenation, acetylation, and acid-treatment gave 3-alkyl-2,5-di-$\text{t}$-butyl-2,4-cyclopentadienones in excellent yield.